Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
ORL · 2023 · 85 (5) · 284-293
DOI: 10.1159/000531995 ↗Kurz gefasst
Fachartikel in der Zeitschrift ORL, online erschienen am 30.08.2023. Verfasst von Ryan T Hughes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Deglutition, Oropharyngeal Neoplasms, Papillomavirus Infections, Robotic Surgical Procedures. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Introduction
The aim of this study was to investigate the impact of primary transoral robotic surgery (TORS) versus radiotherapy (RT) on progression-free survival (PFS), overall survival (OS), and 1-year swallowing function for patients with early-stage HPV-associated oropharyngeal squamous cell carcinoma (OPSCC).
Methods
Patients with stage I-II (AJCC 8th Ed.) HPV-associated OPSCC treated with TORS followed by risk-adapted adjuvant therapy or (chemo)radiotherapy between 2014 and 2019 were identified. PFS, OS, and swallowing outcomes including gastrostomy tube (GT) use/dependence, and Functional Oral Intake Scale (FOIS) change over 1 year were compared.
Results
One hundred sixty-seven patients were analyzed: 116 treated with TORS with or without adjuvant RT and 51 treated with RT (50 chemoRT). The RT group had more advanced tumor/nodal stage, higher comorbidity, and higher rates of concurrent chemotherapy. There were no differences in 3-year PFS (88% TORS vs. 75% RT) or OS (90% vs. 81%) between groups, which persisted after adjusting for stage, age, and comorbidity. GT use/dependence rates were higher in the RT group. Mean (SD) FOIS scores in the TORS group were 6.9 (0.4) at baseline and 6.4 (1.0) at 1 year, compared with 6.7 (0.6) and 5.6 (1.7) for the RT group. Only clinical nodal stage was found to be significantly associated with FOIS change from baseline to 1 year.
Conclusion
There were no differences in PFS or OS between patients treated with primary TORS or RT for early-stage HPV-associated OPSCC. Clinical N2 status is associated with FOIS change at 1 year and may be the major factor affecting long-term swallowing function, irrespective of primary treatment modality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
- Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
- Department of Otolaryngology, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
- Department of Radiation Oncology, Duke University School of Medicine, Durham, North Carolina, USA.
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Hughes, R. T., Levine, B. J., May, N., Shenker, R. F., Yang, J. H., Lanier, C. M., Frizzell, B. A., Greven, K. M., & Waltonen, J. D. (2023). Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. ORL, 85(5), 284-293. https://doi.org/10.1159/000531995
Vancouver
Hughes RT, Levine BJ, May N, Shenker RF, Yang JH, Lanier CM, et al. Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma. ORL. 2023;85(5):284-293. doi:10.1159/000531995
BibTeX
@article{Hughes2023,
author = {Hughes, Ryan T and Levine, Beverly J and May, Nelson and Shenker, Rachel F and Yang, Jae H and Lanier, Claire M and Frizzell, Bart A and Greven, Kathryn M and Waltonen, Joshua D},
title = {Survival and Swallowing Function after Primary Radiotherapy versus Transoral Robotic Surgery for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma},
journal = {ORL},
year = {2023},
volume = {85},
number = {5},
pages = {284--293},
doi = {10.1159/000531995}
}
EUVIMED